Advertisement

Topics

Hansoh Pharma Plans Hong Kong IPO that Could Raise $1-$3 Billion

06:34 EDT 8 Sep 2018 | ChinaBio Today

Hansoh, a China pharma based in Lianyungang, Jiangsu province, has applied to stage an IPO on the Hong Kong exchange. Unlike most companies seeking Hong Kong IPOs, Hansoh is both profitable and established. It claims to be one of the top 30 biopharmas in China, with revenues of $900 million in 2017. Two years ago, when rumors of a Hong Kong IPO first surfaced, it was thought Hansoh's debut would raise between $1.5 and $3 billion. No estimates for this IPO have are publicly available. More details...

Share this with colleagues:

Original Article: Hansoh Pharma Plans Hong Kong IPO that Could Raise $1-$3 Billion

NEXT ARTICLE

More From BioPortfolio on "Hansoh Pharma Plans Hong Kong IPO that Could Raise $1-$3 Billion"

Advertisement
Quick Search
Advertisement
Advertisement